By G HossainPosted on October 22, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The deal focuses on ICT01, a monoclonal antibody being tested in acute myeloid leukemia. ImCheck is also developing assets in infectious disease and other oncology indications. Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody Post navigation Galapagos Plans Cell Therapy Exit, Potentially Affecting 365 EmployeesSoftLedger announces revamped partner program